Type of Scheme |
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks |
Investment Objective |
The investment objective of the scheme is to generate income and capital appreciation from a portfolio primarily investing in Indian equities and equity related securities of large cap and mid cap companies at the time of investment. From time to time, the fund manager may also seek participation in other Indian equity and equity related securities to achieve optimal Portfolio construction. The Scheme does not guarantee or assure any returns |
Fund Managers** |
Mr. Neelesh Surana, (since inception of the fund) and Mr. Ankit Jain (since January 31, 2019) |
Allotment Date |
09th July, 2010 |
Benchmark Index |
Nifty Large Midcap 250 (TRI) |
Minimum Investment Amount |
Fresh lumpsum subscription/switch-in to all the Plans & Options of Mirae Asset Emerging Bluechip Fund through any mode including Stock Exchange platform has been temporarily suspended with effect from October 25, 2016 |
Systematic Investment Plan (SIP) (Any Date SIP is available from 1st July, 2019) |
Fresh Registration through SIP shall be allowed for a maximum of up to ₹ 2,500/-(Rupees Two Thousand Five Hundred) through Monthly mode cumulatively aggregated across all available SIP Dates of each month (at Primary holder PAN level) before the applicable cut off time on any business day For Additional Details please refer notice-cum- addendum dated November 4, 2020 |
Load Structure |
Entry load: NA Exit load: I. For investors who have opted for SWP under the plan: a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil. b) Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: (Redemption of units would be done on First In First Out Basis (FIFO): •If redeemed within 1 year (365 days) from the date of allotment: 1% •If redeemed after 1 year (365 days) from the date of allotment: NIL II. Other Redemptions: For Investors who have not opted for SWP under the plan (including Switch out, STP out): •If redeemed within 1 year (365 days) from the date of allotment: 1% •If redeemed after 1 year (365 days) from the date of allotment: NIL |
Plans Available |
Regular Plan and Direct Plan |
Options Available |
Growth Option and IDCW^ Option (Payout & Re-investment) |
Monthly Average AUM (₹ Cr.) as on March 31, 2022 |
21,217.84 |
Net AUM ( ₹ Cr.) | 21,932.38 |
Monthly Avg. Expense Ratio (Including Statutory Levies) as on March 31, 2022 |
Regular Plan: 1.66% Direct Plan: 0.76% |
**For experience of Fund Managers Click Here | |
^Pursuant to Notice cum addendum dated March 27, 2021 the nomenclature of dividend option has been changed w.e.f. April 01, 2021. |
NAV: | Direct | Regular |
Growth | ₹ 103.711 | ₹ 95.098 |
IDCW | ₹ 67.697 | ₹ 40.663 |
Volatility | 21.65% |
Beta: | 0.92 |
R Squared | 0.98 |
Sharpe Ratio#: | 0.80 |
Information Ratio | 0.89 |
Portfolio Turnover Ratio | 0.63 times |
@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 31st March, 2022.^Basis last rolling 12 months. |
Portfolio Holdings | % Allocation | |
Banks | ||
ICICI Bank Ltd | 5.96% | |
HDFC Bank Ltd | 5.13% | |
Axis Bank Ltd | 4.03% | |
State Bank of India | 3.70% | |
Kotak Mahindra Bank Ltd | 0.45% | |
Software | ||
Infosys Ltd | 5.51% | |
MphasiS Ltd | 1.79% | |
Tata Consultancy Services Ltd | 1.78% | |
HCL Technologies Ltd | 1.70% | |
Pharmaceuticals | ||
Sun Pharmaceutical Industries Ltd | 2.43% | |
IPCA Laboratories Ltd | 1.43% | |
Torrent Pharmaceuticals Ltd | 1.36% | |
Aurobindo Pharma Ltd | 1.33% | |
Ajanta Pharma Ltd | 1.21% | |
Natco Pharma Ltd | 0.82% | |
Finance | ||
Shriram Transport Finance Company Ltd | 1.53% | |
Power Finance Corporation Ltd | 1.08% | |
Housing Development Finance Corporation Ltd | 1.07% | |
SBI Cards and Payment Services Ltd | 0.98% | |
Cholamandalam Investment and Finance Company Ltd | 0.78% | |
Consumer Durables | ||
Bata India Ltd | 1.54% | |
Crompton Greaves Consumer Electricals Ltd | 1.30% | |
Voltas Ltd | 1.27% | |
Havells India Ltd | 1.13% | |
Titan Company Ltd | 0.05% | |
Insurance | ||
Max Financial Services Ltd | 2.16% | |
HDFC Life Insurance Company Ltd | 1.16% | |
SBI Life Insurance Company Ltd | 1.02% | |
ICICI Lombard General Insurance Company Ltd | 0.75% | |
Consumer Non Durables | ||
Emami Ltd | 1.63% | |
ITC Ltd | 1.20% | |
Hindustan Unilever Ltd | 1.06% | |
Britannia Industries Ltd | 0.64% | |
Kansai Nerolac Paints Ltd | 0.48% | |
Dabur India Ltd | 0.00% | |
Petroleum Products | ||
Reliance Industries Ltd | 3.59% | |
Bharat Petroleum Corporation Ltd | 0.73% | |
Hindustan Petroleum Corporation Ltd | 0.32% | |
Auto | ||
Maruti Suzuki India Ltd | 1.34% | |
Tata Motors Ltd | 1.32% | |
Ashok Leyland Ltd | 0.90% | |
TVS Motor Company Ltd | 0.69% | |
Chemicals | ||
Vinati Organics Ltd | 1.66% | |
Atul Ltd | 1.25% | |
Chemplast Sanmar Ltd | 1.11% | |
Auto Ancillaries | ||
Balkrishna Industries Ltd | 1.61% | |
Sona BLW Precision Forgings Ltd | 1.18% | |
Motherson Sumi Wiring India Ltd | 0.59% | |
CEAT Ltd | 0.56% | |
Industrial Products | ||
SKF India Ltd | 2.25% | |
Prince Pipes And Fittings Ltd | 0.70% | |
Bharat Forge Ltd | 0.24% | |
Cement & Cement Products | ||
JK Cement Ltd | 1.93% | |
Nuvoco Vistas Corporation Ltd | 1.06% | |
Gas | ||
Gujarat State Petronet Ltd | 2.19% | |
Capital Markets | ||
Indian Energy Exchange Ltd | 1.06% | |
UTI Asset Management Company Ltd | 0.94% | |
Construction Project | ||
Larsen & Toubro Ltd | 1.93% | |
Telecom - Services | ||
Bharti Airtel Ltd | 1.86% | |
Ferrous Metals | ||
Tata Steel Ltd | 1.76% | |
Healthcare Services | ||
Krishna Institute Of Medical Sciences Ltd | 1.01% | |
Fortis Healthcare Ltd | 0.67% | |
Textile Products | ||
Page Industries Ltd | 1.42% | |
Power | ||
NTPC Ltd | 1.28% | |
Pesticides | ||
Bayer Cropscience Ltd | 0.92% | |
Transportation | ||
Gateway Distriparks Ltd | 0.76% | |
Aerospace & Defense | ||
Bharat Electronics Ltd | 0.62% | |
Non - Ferrous Metals | ||
National Aluminium Company Ltd | 0.36% | |
Financial Technology (FINTECH) | ||
One 97 Communications Ltd | 0.24% | |
Equity Holding Total | 99.54% | |
Cash & Other Receivables | 0.46% | |
Total | 100.00% |
New Position Bought |
Stock |
Auto Ancillaries |
Motherson Sumi Wiring India Limited |
Industrial Products |
Bharat Forge Limited |
Transportation |
Gateway Distriparks Limited |
New Position Bought |
Stock |
Pharmaceuticals |
Dr. Reddy's Laboratories Limited |
Retailing |
Zomato Limited |
Positions Increased |
Stock |
Non - Ferrous Metals |
National Aluminium Company Limited |
Power |
NTPC Limited |
Gas |
Gujarat State Petronet Limited |
Finance |
Shriram Transport Finance Company Limited |
Petroleum Products |
Bharat Petroleum Corporation Limited |
Reliance Industries Limited |
Pharmaceuticals |
Aurobindo Pharma Limited |
Insurance |
ICICI Lombard General Insurance Company Limited |
HDFC Life Insurance Company Limited |
Construction Project |
Larsen & Toubro Limited |
Consumer Durables |
Crompton Greaves Consumer Electricals Limited |
Havells India Limited |
Bata India Limited |
Software |
HCL Technologies Limited |
Banks |
Kotak Mahindra Bank Limited |
Cement & Cement Products |
JK Cement Limited |
Consumer Non Durables |
Hindustan Unilever Limited |
Emami Limited |
Britannia Industries Limited |
Auto |
TVS Motor Company Limited |
Maruti Suzuki India Limited |
Industrial Products |
Prince Pipes And Fittings Limited |
SKF India Limited |
Positions Decreased |
Stock |
Auto |
Tata Motors Limited |
Ashok Leyland Limited |
Aerospace & Defense |
Bharat Electronics Limited |
Consumer Non Durables |
ITC Limited |
Ferrous Metals |
Tata Steel Limited |
Cement & Cement Products |
Nuvoco Vistas Corporation Limited |
Banks |
Axis Bank Limited |
Software |
Tata Consultancy Services Limited |
MphasiS Limited |
Chemicals |
Atul Limited |
Chemplast Sanmar Limited |
Capital Markets |
UTI Asset Management Company Limited |
Healthcare Services |
Krishna Institute Of Medical Sciences Limited |
Consumer Durables |
Voltas Limited |
Pharmaceuticals |
Ajanta Pharma Limited |
Auto Ancillaries |
Sona BLW Precision Forgings Limited |
Record Date | IDCW (₹) | Face Value (₹) | Cum Nav (₹) |
06-Dec-18 |
2.21 per Unit |
10 |
28.972 |
16-Jan-20 |
2.21 per Unit |
10 |
32.767 |
15-Mar-21 |
3.25 per Unit |
10 |
40.346 |
14-Mar-22 |
3.50 per Unit |
10 |
40.731 |
Past Performance may or may not be sustained in future. Pursuant to payment of IDCW the NAV of the IDCW option of the scheme will fall to the extent of payout and statutory levy (if any). IDCW history is for MAEBF- Regular Plan - IDCW Option
Returns (in%) | ||||
Returns (in%) | ||||
1 Yr | 3 Yrs | 5 Yrs | SI | |
MAEBF | 21.07% |
21.23% |
17.44% |
21.16% |
Scheme Benchmark* | 22.90% |
18.31% |
15.11% |
13.44% |
Additional Benchmark** | 19.50% |
16.10% |
15.94% |
12.15% |
NAV as on 31st March, 2022 | 95.098 | |||
Index Value (31st March, 2022) | Index Value of Scheme benchmark is 12,112.92 and S&P BSE Sensex (TRI) is 87,545.23 | |||
Allotment Date | 9th July, 2010 | |||
Scheme Benchmark | *Nifty Large Midcap 250 (TRI) | |||
Additional Benchmark | **S&P BSE Sensex (TRI) |
Fund managers : Mr. Neelesh Surana managing the scheme since 9th July, 2010 & Mr. Ankit Jain since 31st ,January 2019)
Note: Returns below or for 1 year are absolute returns, returns above 1 year are CAGR- Compounded Annualized Growth returns.
Period | Total Amount Invested | Mkt Value as on 31-March-2022 |
SIP |
1,400,000 |
5,720,987 |
10 Yrs |
1,200,000 |
3,967,600 |
7 Yrs |
840,000 |
1,704,576 |
5 Yrs |
600,000 |
1,005,051 |
3 Yrs |
360,000 |
533,380 |
1 Yr |
120,000 |
124,850 |
Returns (%) |
Period |
|||||
SI |
10yrs |
7yrs |
5yrs |
3yrs |
1yr |
|
Fund Return& (%) |
22.38 |
22.63 |
19.88 |
20.78 |
27.32 |
7.62 |
Benchmark Return& (%) |
16.19 |
17.00 |
17.10 |
18.84 |
27.14 |
11.88 |
Add. Benchmark Return& (%) |
14.20 |
14.94 |
16.17 |
17.70 |
22.20 |
12.92 |
& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.
This product is suitable for investors who are seeking*
• Long term capital appreciation
• Large & Midcap fund investing atleast 35% in largecap stock & atleast 35% in midcap stocks
*Investors should consult their financial advisers if they are not clear about the suitability of the product.
Past Performance may or may not be sustained in future.
Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund managers are given in the respective page of the schemes
Different Plans under the scheme has different expense structure. The reference and details provided here in are of Regular Plan - Growth Option